For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
VP, Real-World Evidence Strategy
Matthew has over 20 years' experience designing global real-world evidence solutions to support the development and commercialization of pharmaceutical/biotechnology products and devices. His experience covers a wide-range of therapeutic areas, as well as strategic objectives from natural history programs, external control arm studies for regulatory approval, and global safety-surveillance mandate. His technical expertise includes program strategy and operational structure in disease and product registries, prospective pharmacoeconomic studies, and systematic reviews of scientific literature.
Prior to joining Parexel, Matthew served as Vice President, Real-World Evidence at Worldwide Clinical Trials, where he led a global team responsible for all observational research programs. Matthew had also held senior management roles at inVentiv Health Clinical, Outcome Sciences, ICON Clinical Research (formerly Ovation Research Group), and MetWorks, Inc.
Matthew holds a Bachelor of Arts in Sociology from Boston University.